Operation

Operation

Beyond financial reports: A deep dive into pharmaceutical unit costs and factory cost allocation. Learn how to interpret the numbers to accurately evaluate your business deals and trade-offs.

  • 5 posts

CAR-T Commercialization Challenges (II): Manufacturing Isn't the Only Bottleneck—Hospitals Are Too

Manufacturing makes CAR-T possible. Hospitals make CAR-T scalable. CAR-T's biggest commercialization challenge isn't manufacturing alone. Hospital capacity—from patient selection and leukapheresis to CRS management and reimbursement—may be the real bottleneck limiting market expansion.

CAR-T Commercialization Challenges (I): Why Manufacturing Doesn't Scale—The Vein-to-Vein Supply Chain

CAR-T therapy has delivered remarkable clinical outcomes, yet scaling manufacturing remains one of the industry's greatest challenges. Learn why CAR-T isn't simply selling engineered cells—it's selling an entire vein-to-vein supply chain

Big Markets Don’t Guarantee Business Survival — Operating Models Do

Most people evaluate opportunities by market size. But market size alone does not determine whether a business can survive. What truly matters is whether your operating model can convert demand into sustainable revenue that covers your costs.

How to Calculate Product Unit Cost? from Manufacturing to Pricing

Learn how to calculate product unit cost step-by-step—from direct and indirect manufacturing costs to unit pricing and profit margin. Essential guide for business development and manufacturing professionals.

Strategic Underpricing: How to Profit from “Unprofitable” Orders

How do contract manufacturers turn unprofitable orders into profits? Discover the real cost structure behind CDMO/OEM/ODM strategic underpricing and learn how operational cost management leads to profitability—even with underpriced deals.